Scientists have come up with a technology called 'Trojan horse', which involves inserting nano-particles into brain in order to beat the tumour cells.
The ground-breaking technique, which had been successfully tested, could eventually be used to treat glioblastoma multiforme, which is the most common and aggressive brain tumour in adults, and notoriously difficult to treat.
Many sufferers die within a few months of diagnosis, and just six in every 100 patients with the condition are alive after five years.
The research led by University of Cambridge scientists involved engineering nanostructures containing both gold and cisplatin, a conventional chemotherapy drug, which were released into tumour cells that had been taken from glioblastoma patients and grown in the lab.
Once inside, the 'nanospheres' were exposed to radiotherapy, which caused the gold to release electrons which damaged the cancer cell's DNA and its overall structure, thereby enhancing the impact of the chemotherapy drug, and eventually was so effective that 20 days later, that the cell culture showed no evidence of any revival.
The study is reported in the Royal Society of Chemistry journal, Nanoscale.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
